Anthony Turkiewicz

4.9k total citations
10 papers, 208 citations indexed

About

Anthony Turkiewicz is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Anthony Turkiewicz has authored 10 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 7 papers in Immunology and 4 papers in Hematology. Recurrent topics in Anthony Turkiewicz's work include Spondyloarthritis Studies and Treatments (6 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Anthony Turkiewicz is often cited by papers focused on Spondyloarthritis Studies and Treatments (6 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Anthony Turkiewicz collaborates with scholars based in United States, Canada and United Kingdom. Anthony Turkiewicz's co-authors include Larry W. Moreland, Gim Gee Teng, Warren D. Blackburn, W. Winn Chatham, Philip J. Mease, Luke Peterson, Majed Khraishi, Roy Fleischmann, Oliver FitzGerald and Bengt Hoepken and has published in prestigious journals such as Journal of Leukocyte Biology, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

Anthony Turkiewicz

10 papers receiving 200 citations

Peers

Countries citing papers authored by Anthony Turkiewicz

Since Specialization

Citations

This map shows the geographic impact of Anthony Turkiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Turkiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Turkiewicz more than expected).

Fields of papers citing papers by Anthony Turkiewicz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Turkiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Turkiewicz. The network helps show where Anthony Turkiewicz may publish in the future.

Co-authorship network of co-authors of Anthony Turkiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Turkiewicz. A scholar is included among the top collaborators of Anthony Turkiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Turkiewicz. Anthony Turkiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations 2022 ·The Journal of Rheumatology ·Lihi Eder, Ashish Jacob Mathew, Philippe Carron, Heidi Bertheussen, Juan D. Cañete, (unknown), Andrea Delle Sedie, Carlo Salvarani, Roberto Ranza, (unknown), Anthony Turkiewicz, (unknown), Hülya Bükülmez, Maria Stoenoiu, Arthur M. Mandelin, (unknown), Chris A. Lindsay, Evan Siegel, Philip J. Mease	10
2	Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2) 2020 ·Rheumatology and Therapy ·Ana‐Maria Orbai, Jordi Gratacós, Anthony Turkiewicz, Stephen Hall, Eva Dokoupilová, Bernard Combe, Peter Nash, Gaia Gallo, Clinton C. Bertram, (unknown), (unknown), Julie Birt, (unknown), (unknown), Arnaud Constantin	13
3	Improvement from ixekizumab treatment in patients with psoriatic arthritis who have had an inadequate response to one or two TNF inhibitors 2020 ·Lara D. Veeken ·Bruce Kirkham, (unknown), (unknown), (unknown), Chen‐Yen Lin, Anthony Turkiewicz	4
4	Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age 2019 ·Arthritis Research & Therapy ·John Tesser, Shelly Kafka, Raphael J. DeHoratius, Stephen Xu, Elizabeth C. Hsia, Anthony Turkiewicz	7
5	4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis 2018 ·RMD Open ·Désirée van der Heijde, Atul Deodhar, Oliver FitzGerald, Roy Fleischmann, Dafna D. Gladman, Alice B. Gottlieb, Bengt Hoepken, Lars Bauer, (unknown), Majed Khraishi, Luke Peterson, Anthony Turkiewicz, J. Wollenhaupt, Philip J. Mease	30
6	Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposure 2015 ·RMD Open ·Philip J. Mease, Atul Deodhar, Roy Fleischmann, J. Wollenhaupt, Dafna D. Gladman, Piotr Leszczyński, Pavel Vítek, Anthony Turkiewicz, Majed Khraishi, Oliver FitzGerald, Robert Landewé, M. de Longueville, Bengt Hoepken, Luke Peterson, D. van der Heijde	41
7	Psoriatic arthritis: Current concepts on pathogenesis‐oriented therapeutic options 2007 ·Arthritis & Rheumatism ·Anthony Turkiewicz, Larry W. Moreland	40
8	Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis 2005 ·Expert Opinion on Biological Therapy ·Gim Gee Teng, Anthony Turkiewicz, Larry W. Moreland	31
9	Clinical images: Syrinx‐induced Charcot shoulder 2004 ·Arthritis & Rheumatism ·Anthony Turkiewicz, Gail S. Kerr	5
10	Determinants of neutrophil HOCI generation: ligand-dependent responses and the role of surface adhesion 1994 ·Journal of Leukocyte Biology ·W. Winn Chatham, Anthony Turkiewicz, Warren D. Blackburn	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact